Bayforest Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,190
Closed -$333K 885
2025
Q1
$333K Buy
9,190
+6,046
+192% +$219K 0.14% 269
2024
Q4
$132K Buy
+3,144
New +$132K 0.17% 240